Rigel Pharmaceuticals
RIGL
#6826
Rank
โ‚ฌ0.53 B
Marketcap
29,41ย โ‚ฌ
Share price
-0.85%
Change (1 day)
39.20%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2025 (TTM): โ‚ฌ0.10 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.28 Billion. In 2024 the company made an earning of โ‚ฌ22.17 Million, an increase over its 2023 earnings that were of -โ‚ฌ15.37 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.10 B380.24%
2024 โ‚ฌ22.17 M-244.27%
2023 -โ‚ฌ15.37 Million-66.79%
2022 -โ‚ฌ46.29 Million340.73%
2021 -โ‚ฌ10.51 Million-56.15%
2020 -โ‚ฌ23.96 Million-57.34%
2019 -โ‚ฌ56.15 Million-7.66%
2018 -โ‚ฌ60.81 Million-9.47%
2017 -โ‚ฌ67.17 Million24.46%
2016 -โ‚ฌ53.97 Million23.63%
2015 -โ‚ฌ43.66 Million-43.29%
2014 -โ‚ฌ76.98 Million2.5%
2013 -โ‚ฌ75.11 Million
2010 โ‚ฌ31.93 M-133.97%
2009 -โ‚ฌ94.01 Million-18.49%
2008 -โ‚ฌ0.12 Billion71.91%
2007 -โ‚ฌ67.09 Million84.74%
2006 -โ‚ฌ36.32 Million-10.17%
2005 -โ‚ฌ40.43 Million-15.73%
2004 -โ‚ฌ47.98 Million39.29%
2003 -โ‚ฌ34.45 Million10.3%
2002 -โ‚ฌ31.23 Million48.3%
2001 -โ‚ฌ21.06 Million-2.13%
2000 -โ‚ฌ21.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚ฌ6.95 B 6,662.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ11.04 B 10,637.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-โ‚ฌ91.98 Million-189.43%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI
-โ‚ฌ0.12 Billion-207.13%๐Ÿ‡บ๐Ÿ‡ธ USA